Large-scale testing (Phase 3)Study completedNCT01755156
What this trial is testing
Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 402